HT
Hengrui Therapeutics
Shutdownhengruitherapeutics.com
Website unreachable since Oct 20, 2026
Hengrui Therapeutics develops targeted oncology drugs utilizing advanced biomarker identification and precision medicine techniques to improve treatment outcomes for cancer patients. The company focuses on addressing the limitations of traditional therapies by providing personalized treatment options that enhance efficacy and minimize side effects.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Hengrui Therapeutics develops targeted oncology drugs utilizing advanced biomarker identification and precision medicine techniques to improve treatment outcomes for cancer patients. The company focuses on addressing the limitations of traditional therapies by providing personalized treatment options that enhance efficacy and minimize side effects.